Gives no cost drugs to people with out coverage protection or who will't fork out for his or her Genentech medicine. The latter acts to improve levels of GLP-one. The primary result is change in MoCA scores. Secondary outcomes involve RBANS, alter in olfactory brain activation on MRI, olfactory function, https://jonathank665whs8.sharebyblog.com/profile